Cancer care has changed dramatically over the last decade. As opposed to a "one-size-fits-all" approach, treatment today is ...

Preconfigured applications: DRAGEN v4.4 will offer "push-button" analysis for oncology workflows, including the first and ...

Dr Rahila Sardar, Co-founder and CEO, Vgenomics India talks about the role of AI and genomics in diagnosing the rare diseases ...

Qiagen has a relatively well-diversified portfolio across four segments. Find out my recommendation on QGEN stock here.

QGEN inks an agreement to acquire Genoox for $70 million in cash. The acquisition expands QIAGEN's QDI portfolio.

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Emergen Research Logo Driven by Advances in Gene Sequencing and Growing Need for Precision MedicineVANCOUVER, BRITISH COLUMBIA, CA ...

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases ...

During a live event, Shuo Ma, MD, PhD, discussed the resistance mutation analysis of patients who had disease progression ...

Learn how single-cell transcriptomics is helping researchers explore gene activity and immune system diseases with ...

Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global ...